Biological effects of passive scattering and spot scanning proton beams at the distal end of the spread-out Bragg peak in single cells and multicell spheroids

References

• Ando K, Furusawa Y, Suzuki M, Nojima K, Majima H, Koike S, Aoki M, Shimizu W, Futami Y, Ogino T, et al. 2001. Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. J Radiat Res. 42(1):79–89.
   PubMed Web of Science ®Google Scholar
• Bassler N, Toftegaard J, Lühr A, Sorensen BS, Scifoni E, Krämer M, Jäkel O, Mortensen LS, Overgaard J, Petersen JB. 2014. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol. 53(1):25–32.
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Marshall TI, Currell FJ, Kacperek A, Schettino G, Prise KM. 2016. Variations in the processing of DNA double-strand breaks along 60-MeV therapeutic proton beams. Int J Radiat Oncol Biol Phys. 95(1):86–94.
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Marshall TI, Perozziello FM, Manti L, Currell FJ, Hanton F, McMahon SJ, Kavanagh JN, Cirrone GAP, Romano F, et al. 2014. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int J Radiat Oncol Biol Phys. 90(1):27–35.
   PubMed Web of Science ®Google Scholar
• Dowdell S, Grassberger C, Sharp G, Paganetti H. 2016. Fractionated lung IMPT treatments: sensitivity to setup uncertainties and motion effects based on single-field homogeneity. Technol Cancer Res Treat. 15(5):689–696.
   PubMed Web of Science ®Google Scholar
• Dubessy C, Merlin JL, Marchal C, Guillemin F. 2000. Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol. 36(2–3):179–192.
   PubMed Web of Science ®Google Scholar
• Gentile MS, Yeap BY, Paganetti H, Goebel CP, Gaudet DE, Gallotto SL, Weyman EA, Morgan ML, MacDonald SM, Giantsoudi D, et al. 2018. Brainstem injury in pediatric patients with posterior fossa tumors treated with proton beam therapy and associated dosimetric factors. Int J Radiat Oncol Biol Phys. 100(3):719–729.
   PubMed Web of Science ®Google Scholar
• Giantsoudi D, Sethi RV, Yeap BY, Eaton BR, Ebb DH, Caruso PA, Rapalino O, Chen YLE, Adams JA, Yock TI, et al. 2016. Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma: LET and RBE associations for areas of injury. Int J Radiat Oncol Biol Phys. 95(1):287–296.
   PubMed Web of Science ®Google Scholar
• Gorgisyan J, Munck af Rosenschold P, Perrin R, Persson GF, Josipovic M, Belosi MF, Engelholm SA, Weber DC, Lomax AJ. 2017. Feasibility of pencil beam scanned intensity modulated proton therapy in breath-hold for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 99(5):1121–1128.
   PubMed Web of Science ®Google Scholar
• Grassberger C, Paganetti H. 2011. Elevated LET components in clinical proton beams. Phys Med Biol. 56(20):6677–6691.
   Google Scholar
• Gridley DS, Pecaut MJ, Mao XW, Wroe AJ, Luo-Owen X. 2015. Biological effects of passive versus active scanning proton beams on human lung epithelial cells. Technol Cancer Res Treat. 14(1):81–98.
   PubMed Web of Science ®Google Scholar
• Guan F, Bronk L, Titt U, Lin SH, Mirkovic D, Kerr MD, Zhu XR, Dinh J, Sobieski M, Stephan C, et al. 2015a. Spatial mapping of the biologic effectiveness of scanned particle beams: Towards biologically optimized particle therapy. Sci Rep. 5(1):9850.
   PubMedGoogle Scholar
• Guan F, Geng C, Ma D, Bronk L, Kerr M, Li Y, Gates D, Kroger B, Sahoo N, Titt U, et al. 2018. RBE model-based biological dose optimization for proton radiobiology studies. Int J Part Ther. 5(1):160–171.
   PubMedGoogle Scholar
• Guan F, Peeler C, Bronk L, Geng C, Taleei R, Randeniya S, Ge S, Mirkovic D, Grosshans D, Mohan R, et al. 2015b. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 42(11):6234–6247.
   PubMed Web of Science ®Google Scholar
• Gueulette J, Blattmann H, Pedroni E, Coray A, De Coster BM, Mahy P, Wambersie A, Goitein G. 2005. Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion. Int J Radiat Oncol Biol Phys. 62(3):838–845.
   PubMed Web of Science ®Google Scholar
• Gueulette J, Böhm L, Slabbert JP, De Coster BM, Rutherfoord GS, Ruifrok A, Octave-Prignot M, Binns PJ, Schreuder AN, Symons JE, et al. 2000. Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses. Int J Radiat Oncol Biol Phys. 47(4):1051–1058.
   PubMed Web of Science ®Google Scholar
• Hall N, Rouge B. 2015. The physics of proton therapy. Phys Med Biol. 60(8):R155–R209.
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Sugie C, Iwata H, Ogino H, Omachi C, Yasui K, Mizoe J. e, Shibamoto Y. 2018. Recovery from sublethal damage and potentially lethal damage: proton beam irradiation vs. X‐ray irradiation. Strahlenther Onkol. 194(4):343–351.
   PubMed Web of Science ®Google Scholar
• Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. 2010. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 148(1):3–15.
   PubMed Web of Science ®Google Scholar
• Hojo H, Dohmae T, Hotta K, Kohno R, Motegi A, Yagishita A, Makinoshima H, Tsuchihara K, Akimoto T. 2017. Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak. Radiat Oncol. 12(1):1–9.
   PubMedGoogle Scholar
• Iwata H, Matsufuji N, Toshito T, Akagi T, Otsuka S, Shibamoto Y. 2013. Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses. J Radiat Res. 54(2):367–373.
   PubMed Web of Science ®Google Scholar
• Iwata H, Ogino H, Hashimoto S, Yamada M, Shibata H, Yasui K, Toshito T, Omachi C, Tatekawa K, Manabe Y, et al. 2016. Spot scanning and passive scattering proton therapy: relative biological effectiveness and oxygen enhancement ratio in cultured cells. Int J Radiat Oncol Biol Phys. 95(1):95–102.
   PubMed Web of Science ®Google Scholar
• Iwata H, Shuto T, Kamei S, Omachi K, Moriuchi M, Omachi C, Toshito T, Hashimoto S, Nakajima K, Sugie C, et al. 2020. Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution. J Radiat Res. 61(6):832–841.
   PubMed Web of Science ®Google Scholar
• Mohan R, Grosshans D. 2017. Proton therapy - present and future. Adv Drug Deliv Rev. 109:26–44.
   PubMed Web of Science ®Google Scholar
• Mohan R, Peeler CR, Guan F, Bronk L, Cao W, Grosshans DR. 2017. Radiobiological issues in proton therapy. Acta Oncol. 56(11):1367–1373.
   PubMed Web of Science ®Google Scholar
• Paganetti H. 2014. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 59(22):R419–R472.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Schmitz T. 1996. The influence of the beam modulation technique on dose and RBE in proton radiation therapy. Phys Med Biol. 41(9):1649–1663.
   PubMed Web of Science ®Google Scholar
• Petrović I, Ristić-Fira A, Todorović D, Korićanac L, Valastro L, Cirrone P, Cuttone G. 2010. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak. Int J Radiat Biol. 86(9):742–751.
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Nishimoto S, Mi F, Sasai K, Kagiya T, Abe M. 1987. Evaluation of various types of new hypoxic cell sensitizers using the EMT6 single cell-spheroid-solid tumour system. Int J Radiat Biol Relat Stud Phys Chem Med. 52(3):347–357.
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Ono K, Takahashi M, Abe M, Kano E, Hori H, Shibata T, Inayama S. 1986. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells. Jpn J Cancer Res. 77(10):1027–1033.
   PubMedGoogle Scholar
• Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, Tomita N. 2012. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model. J Radiat Res. 53(1):1–9.
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Takahashi M, Ono K, Komuro C, Abe M. 1985. Recovery from potentially lethal damage after X-irradiation in three experimental tumors in mice. Jpn J Cancer Res. 76(4):278–283.
   PubMedGoogle Scholar
• Slabbert J, Martinez J, De Coster B-M, Gueulette J. 2015. Increased proton relative biological effectiveness at the very end of a spread-out Bragg peak for jejunum irradiated ex vivo. Int J Part Ther. 2(1):37–43.
   Google Scholar
• Snider JW, Schneider RA, Poelma-Tap D, Stieb S, Murray FR, Placidi L, Albertini F, Lomax A, Bolsi A, Kliebsch U, et al. 2018. Long-term outcomes and prognostic factors after pencil-beam scanning proton radiation therapy for spinal chordomas: a large, single-institution cohort. Int J Radiat Oncol Biol Phys. 101(1):226–233.
   PubMed Web of Science ®Google Scholar
• Toshito T, Omachi C, Kibe Y, Sugai H, Hayashi K, Shibata H, Yasui K, Tanaka K, Yamamoto T, Yoshida A, et al. 2016. A proton therapy system in Nagoya Proton Therapy Center. Australas Phys Eng Sci Med. 39(3):645–654.
   PubMed Web of Science ®Google Scholar
• Tran LT, Chartier L, Bolst D, Pogossov A, Guatelli S, Petasecca M, Lerch MLF, Prokopovich DA, Reinhard MI, Clasie B, et al. 2017. Characterization of proton pencil beam scanning and passive beam using a high spatial resolution solid-state microdosimeter. Med Phys. 44(11):6085–6095.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Botas P, Giantsoudi D, Gorissen BL, Paganetti H. 2016. Reoptimization of intensity modulated proton therapy plans based on linear energy transfer. Int J Radiat Oncol Biol Phys. 96(5):1097–1106.
   PubMed Web of Science ®Google Scholar
• Vitti ET, Parsons JL. 2019. The radiobiological effects of proton beam therapy: Impact on DNA damage and repair. Cancers (Basel). 11(7):946–915.
   Web of Science ®Google Scholar
• Wo JY, Plastaras JP, Metz JM, Jiang W, Yeap BY, Drapek LC, Adams J, Baglini C, Ryan DP, Murphy JE, et al. 2019. Pencil beam scanning proton beam chemoradiation therapy with 5-Fluorouracil and Mitomycin-C for definitive treatment of carcinoma of the anal canal: a multi-institutional pilot feasibility study. Int J Radiat Oncol Biol Phys. 105(1):90–95.
   PubMed Web of Science ®Google Scholar